Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Active-controlled, Randomized, Evaluator and Subject Blinded, Split-face, Comparative, Non-inferiority and Confirmatory Clinical Study of the Efficacy and Safety Between YYD701-2 and Restylane Perlane Lidocaine for Temporary Correction of Moderate to Severe Nasolabial Folds

NCT03170050 is registered in ClinicalTrials.gov with Yooyoung Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT03170050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03170050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Active-controlled, Randomized, Evaluator and Subject Blinded, Split-face, Comparative, Non-inferiority and Confirmatory Clinical Study of the Efficacy and Safety Between YYD701-2 and Restylane Perlane Lidocaine for Temporary Correction of Moderate to Severe Nasolabial Folds
Lead sponsor
Yooyoung Pharmaceutical Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
March 1, 2017
Completion date
November 21, 2017
Enrollment
107 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

wrinkle severity rating scale(wsrs) grade 3 (moderate) or 4 (severe) of nasolabial folds